Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

2009 ◽  
Author(s):  
Rob Burger ◽  
Leslie Randall
Keyword(s):  
Ovarian Cancer ◽  
Randomised Controlled Trial ◽  
Controlled Trial ◽  
Advanced Ovarian Cancer ◽  
Open Label ◽  
Phase 3 ◽  
Dose Dense ◽  
Randomised Controlled

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

The Lancet ◽  
2009 ◽  
Vol 374 (9698) ◽  
pp. 1331-1338 ◽  
Author(s):  
Noriyuki Katsumata ◽  
Makoto Yasuda ◽  
Fumiaki Takahashi ◽  
Seiji Isonishi ◽  
Toshiko Jobo ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Randomised Controlled Trial ◽  
Controlled Trial ◽  
Advanced Ovarian Cancer ◽  
Open Label ◽  
Phase 3 ◽  
Dose Dense ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document